Pharmacovigilance is a top priority in healthcare around the world.
The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.
To ensure patient health care through increasing the effectiveness and safety of our medicinal products.
One of the primary goals is to ensure the safety and quality of all its medicinal products. As the WNB's Pharmacovigilance department seeks to make a continuous evaluation of the benefit / risk balance to all of our marketed products that is actually used by the patients.
WNB realizes that new information always appears and it can have an impact on the benefit / risk balance of any of our marketed products. One of the most important goals of Pharmacovigilance is to make a detailed and comprehensive evaluation of this information to ensure the safe use of all products. This is why WNB established the PV department.
Part from the Pharmacovigilance department’s responsibilities is to specify and collect information about any adverse drug reactions related to the use of any of our products then analyze it properly to prevent these events from happening again and to make our products safer for the patients.
Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
WNB is reminding HCP and public to report any safety information regarding its medicinal products including adverse drug reactions, medications errors, lack of efficacy and other medicine related problems through the following,
pv.report@wnb-eg.com